Dr. Furth has guided the Children’s Hospital of Philadelphia Research Institute to catalyze innovation in cell and gene therapy research, as well as omics and big data initiatives. Under her leadership, the institute’s 1,000-plus principal investigators and their teams have developed many translational research programs, including gene therapies for blood disorders, gene editing for inherited disease, and exploration of how the microbiome influences health and disease. She has also championed programs supporting science, technology, engineering, math and medicine in underrepresented populations from high school through postdoctoral training. In 2023, she was elected to the National Academy of Medicine, which recognizes scientific professionals who are shaping health research, practice and policies to improve outcomes for millions. Dr. Furth has led the international Chronic Kidney Disease in Children cohort for more than two decades, a study that has changed how children with kidney disease are assessed for risk factors so interventions can be made earlier.
